2015-2027 Global Alzheimer's Disease Drug Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

April 2020 | 105 pages | ID: 27957087729DEN
Maia Research

Abstracts

The worldwide market for Alzheimer's Disease Drug is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Daiichi Sankyo
Allergan
Johnson & Johnson
Novartis
Merz Pharma
Pfizer
Lundbeck
Eisai

Major Types Covered
Cholinergic
Memantine
Combined Drug

Major Applications Covered
CNS
Cancer
Immunology
Ophthalmology

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Alzheimer's Disease Drug Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Alzheimer's Disease Drug Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE ALZHEIMER'S DISEASE DRUG MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL ALZHEIMER'S DISEASE DRUG MARKET-SEGMENTATION BY TYPE

5.1 Cholinergic
5.2 Memantine
5.3 Combined Drug

6 GLOBAL ALZHEIMER'S DISEASE DRUG MARKET-SEGMENTATION BY APPLICATION

6.1 CNS
6.2 Cancer
6.3 Immunology
6.4 Ophthalmology

7 GLOBAL ALZHEIMER'S DISEASE DRUG MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Daiichi Sankyo
  8.1.1 Daiichi Sankyo Profile
  8.1.2 Daiichi Sankyo Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Daiichi Sankyo Product/Solution Launches and Enhancements Analysis
  8.1.4 Daiichi Sankyo Business Overview/Recent Development/Acquisitions
8.2 Allergan
  8.2.1 Allergan Profile
  8.2.2 Allergan Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Allergan Product/Solution Launches and Enhancements Analysis
  8.2.4 Allergan Business Overview/Recent Development/Acquisitions
8.3 Johnson & Johnson
  8.3.1 Johnson & Johnson Profile
  8.3.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
  8.3.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.4 Novartis
  8.4.1 Novartis Profile
  8.4.2 Novartis Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Novartis Product/Solution Launches and Enhancements Analysis
  8.4.4 Novartis Business Overview/Recent Development/Acquisitions
8.5 Merz Pharma
  8.5.1 Merz Pharma Profile
  8.5.2 Merz Pharma Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Merz Pharma Product/Solution Launches and Enhancements Analysis
  8.5.4 Merz Pharma Business Overview/Recent Development/Acquisitions
8.6 Pfizer
  8.6.1 Pfizer Profile
  8.6.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Pfizer Product/Solution Launches and Enhancements Analysis
  8.6.4 Pfizer Business Overview/Recent Development/Acquisitions
8.7 Lundbeck
  8.7.1 Lundbeck Profile
  8.7.2 Lundbeck Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Lundbeck Product/Solution Launches and Enhancements Analysis
  8.7.4 Lundbeck Business Overview/Recent Development/Acquisitions
8.8 Eisai
  8.8.1 Eisai Profile
  8.8.2 Eisai Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Eisai Product/Solution Launches and Enhancements Analysis
  8.8.4 Eisai Business Overview/Recent Development/Acquisitions

9 GLOBAL ALZHEIMER'S DISEASE DRUG MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Alzheimer's Disease Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Alzheimer's Disease Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Alzheimer's Disease Drug Production Analysis from 2015-2020
10.4 North America Alzheimer's Disease Drug Consumption Analysis from 2015-2020
10.5 North America Alzheimer's Disease Drug Import and Export from 2015-2020
10.6 North America Alzheimer's Disease Drug Value, Production and Market Share by Type (2015-2020)
10.7 North America Alzheimer's Disease Drug Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Alzheimer's Disease Drug by Country (United States, Canada)
  10.8.1 North America Alzheimer's Disease Drug Sales by Country (2015-2020)
  10.8.2 North America Alzheimer's Disease Drug Consumption Value by Country (2015-2020)
10.9 North America Alzheimer's Disease Drug Market PEST Analysis

11 EUROPE

11.1 Europe Alzheimer's Disease Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Alzheimer's Disease Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Alzheimer's Disease Drug Production Analysis from 2015-2020
11.4 Europe Alzheimer's Disease Drug Consumption Analysis from 2015-2020
11.5 Europe Alzheimer's Disease Drug Import and Export from 2015-2020
11.6 Europe Alzheimer's Disease Drug Value, Production and Market Share by Type (2015-2020)
11.7 Europe Alzheimer's Disease Drug Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Alzheimer's Disease Drug by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Alzheimer's Disease Drug Sales by Country (2015-2020)
  11.8.2 Europe Alzheimer's Disease Drug Consumption Value by Country (2015-2020)
11.9 Europe Alzheimer's Disease Drug Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Alzheimer's Disease Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Alzheimer's Disease Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Alzheimer's Disease Drug Production Analysis from 2015-2020
12.4 Asia-Pacific Alzheimer's Disease Drug Consumption Analysis from 2015-2020
12.5 Asia-Pacific Alzheimer's Disease Drug Import and Export from 2015-2020
12.6 Asia-Pacific Alzheimer's Disease Drug Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Alzheimer's Disease Drug Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Alzheimer's Disease Drug by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Alzheimer's Disease Drug Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Alzheimer's Disease Drug Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Alzheimer's Disease Drug Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Alzheimer's Disease Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Alzheimer's Disease Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Alzheimer's Disease Drug Production Analysis from 2015-2020
13.4 Latin America Alzheimer's Disease Drug Consumption Analysis from 2015-2020
13.5 Latin America Alzheimer's Disease Drug Import and Export from 2015-2020
13.6 Latin America Alzheimer's Disease Drug Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Alzheimer's Disease Drug Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Alzheimer's Disease Drug by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Alzheimer's Disease Drug Sales by Country (2015-2020)
  13.8.2 Latin America Alzheimer's Disease Drug Consumption Value by Country (2015-2020)
13.9 Latin America Alzheimer's Disease Drug Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Alzheimer's Disease Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Alzheimer's Disease Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Alzheimer's Disease Drug Production Analysis from 2015-2020
14.4 Middle East & Africa Alzheimer's Disease Drug Consumption Analysis from 2015-2020
14.5 Middle East & Africa Alzheimer's Disease Drug Import and Export from 2015-2020
14.6 Middle East & Africa Alzheimer's Disease Drug Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Alzheimer's Disease Drug Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Alzheimer's Disease Drug by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Alzheimer's Disease Drug Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Alzheimer's Disease Drug Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Alzheimer's Disease Drug Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL ALZHEIMER'S DISEASE DRUG MARKET FROM 2020-2027

15.1 Future Forecast of the Global Alzheimer's Disease Drug Market from 2020-2027 Segment by Region
15.2 Global Alzheimer's Disease Drug Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Alzheimer's Disease Drug Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Alzheimer's Disease Drug Market Value ($) and Growth Rate of Alzheimer's Disease Drug from 2015-2027
Global Alzheimer's Disease Drug Production and Growth Rate Segment by Product Type from 2015-2027
Global Alzheimer's Disease Drug Consumption and Growth Rate Segment by Application from 2015-2027
Figure Alzheimer's Disease Drug Picture
Table Product Specifications of Alzheimer's Disease Drug
Table Driving Factors for this Market
Table Industry News of Alzheimer's Disease Drug Market
Figure Value Chain Status of Alzheimer's Disease Drug
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Alzheimer's Disease Drug Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Alzheimer's Disease Drug Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Cholinergic of Alzheimer's Disease Drug
Figure Memantine of Alzheimer's Disease Drug
Figure Combined Drug of Alzheimer's Disease Drug
Table Global Alzheimer's Disease Drug Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Alzheimer's Disease Drug Value ($) and Growth Rate Segment by Application from 2015-2020
Figure CNS of Alzheimer's Disease Drug
Figure Cancer of Alzheimer's Disease Drug
Figure Immunology of Alzheimer's Disease Drug
Figure Ophthalmology of Alzheimer's Disease Drug
Table Global Alzheimer's Disease Drug Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Alzheimer's Disease Drug Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Alzheimer's Disease Drug
Figure Online Channel of Alzheimer's Disease Drug
Table Daiichi Sankyo Profile (Company Name, Plants Distribution, Sales Region)
Figure Daiichi Sankyo Sales and Growth Rate from 2015-2020
Figure Daiichi Sankyo Revenue ($) and Global Market Share from 2015-2020
Table Daiichi Sankyo Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Allergan Profile (Company Name, Plants Distribution, Sales Region)
Figure Allergan Sales and Growth Rate from 2015-2020
Figure Allergan Revenue ($) and Global Market Share from 2015-2020
Table Allergan Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson & Johnson Sales and Growth Rate from 2015-2020
Figure Johnson & Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson & Johnson Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis Sales and Growth Rate from 2015-2020
Figure Novartis Revenue ($) and Global Market Share from 2015-2020
Table Novartis Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merz Pharma Profile (Company Name, Plants Distribution, Sales Region)
Figure Merz Pharma Sales and Growth Rate from 2015-2020
Figure Merz Pharma Revenue ($) and Global Market Share from 2015-2020
Table Merz Pharma Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Lundbeck Profile (Company Name, Plants Distribution, Sales Region)
Figure Lundbeck Sales and Growth Rate from 2015-2020
Figure Lundbeck Revenue ($) and Global Market Share from 2015-2020
Table Lundbeck Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Eisai Profile (Company Name, Plants Distribution, Sales Region)
Figure Eisai Sales and Growth Rate from 2015-2020
Figure Eisai Revenue ($) and Global Market Share from 2015-2020
Table Eisai Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Alzheimer's Disease Drug Production Value ($) by Region from 2015-2020
Table Global Alzheimer's Disease Drug Production Value Share by Region from 2015-2020
Table Global Alzheimer's Disease Drug Production by Region from 2015-2020
Table Global Alzheimer's Disease Drug Consumption Value ($) by Region from 2015-2020
Table Global Alzheimer's Disease Drug Consumption by Region from 2015-2020
Table North America Alzheimer's Disease Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Alzheimer's Disease Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Alzheimer's Disease Drug Import and Export from 2015-2020
Table North America Alzheimer's Disease Drug Value ($) by Type (2015-2020)
Table North America Alzheimer's Disease Drug Production by Type (2015-2020)
Table North America Alzheimer's Disease Drug Consumption by Application (2015-2020)
Table North America Alzheimer's Disease Drug Consumption by Country (2015-2020)
Table North America Alzheimer's Disease Drug Consumption Value ($) by Country (2015-2020)
Figure North America Alzheimer's Disease Drug Market PEST Analysis
Table Europe Alzheimer's Disease Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Alzheimer's Disease Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Alzheimer's Disease Drug Import and Export from 2015-2020
Table Europe Alzheimer's Disease Drug Value ($) by Type (2015-2020)
Table Europe Alzheimer's Disease Drug Production by Type (2015-2020)
Table Europe Alzheimer's Disease Drug Consumption by Application (2015-2020)
Table Europe Alzheimer's Disease Drug Consumption by Country (2015-2020)
Table Europe Alzheimer's Disease Drug Consumption Value ($) by Country (2015-2020)
Figure Europe Alzheimer's Disease Drug Market PEST Analysis
Table Asia-Pacific Alzheimer's Disease Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Alzheimer's Disease Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Alzheimer's Disease Drug Import and Export from 2015-2020
Table Asia-Pacific Alzheimer's Disease Drug Value ($) by Type (2015-2020)
Table Asia-Pacific Alzheimer's Disease Drug Production by Type (2015-2020)
Table Asia-Pacific Alzheimer's Disease Drug Consumption by Application (2015-2020)
Table Asia-Pacific Alzheimer's Disease Drug Consumption by Country (2015-2020)
Table Asia-Pacific Alzheimer's Disease Drug Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Alzheimer's Disease Drug Market PEST Analysis
Table Latin America Alzheimer's Disease Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Alzheimer's Disease Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Alzheimer's Disease Drug Import and Export from 2015-2020
Table Latin America Alzheimer's Disease Drug Value ($) by Type (2015-2020)
Table Latin America Alzheimer's Disease Drug Production by Type (2015-2020)
Table Latin America Alzheimer's Disease Drug Consumption by Application (2015-2020)
Table Latin America Alzheimer's Disease Drug Consumption by Country (2015-2020)
Table Latin America Alzheimer's Disease Drug Consumption Value ($) by Country (2015-2020)
Figure Latin America Alzheimer's Disease Drug Market PEST Analysis
Table Middle East & Africa Alzheimer's Disease Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Alzheimer's Disease Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Alzheimer's Disease Drug Import and Export from 2015-2020
Table Middle East & Africa Alzheimer's Disease Drug Value ($) by Type (2015-2020)
Table Middle East & Africa Alzheimer's Disease Drug Production by Type (2015-2020)
Table Middle East & Africa Alzheimer's Disease Drug Consumption by Application (2015-2020)
Table Middle East & Africa Alzheimer's Disease Drug Consumption by Country (2015-2020)
Table Middle East & Africa Alzheimer's Disease Drug Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Alzheimer's Disease Drug Market PEST Analysis
Table Global Alzheimer's Disease Drug Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Alzheimer's Disease Drug Production and Growth Rate Forecast by Region (2020-2027)
Table Global Alzheimer's Disease Drug Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Alzheimer's Disease Drug Production and Growth Rate Forecast by Type (2020-2027)
Table Global Alzheimer's Disease Drug Consumption and Growth Rate Forecast by Application (2020-2027)